These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 31245502)
1. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells. Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502 [TBL] [Abstract][Full Text] [Related]
2. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine. Nagashima T; Shimizu K; Matsumoto R; Honda H Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448 [TBL] [Abstract][Full Text] [Related]
3. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells. Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124 [TBL] [Abstract][Full Text] [Related]
4. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. Tano K; Yasuda S; Kuroda T; Saito H; Umezawa A; Sato Y PLoS One; 2014; 9(10):e110496. PubMed ID: 25347300 [TBL] [Abstract][Full Text] [Related]
5. Cold Atmospheric Pressure Plasma-Activated Medium Induces Selective Cell Death in Human Hepatocellular Carcinoma Cells Independently of Singlet Oxygen, Hydrogen Peroxide, Nitric Oxide and Nitrite/Nitrate. Li Y; Tang T; Lee H; Song K Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074016 [TBL] [Abstract][Full Text] [Related]
6. Engineering of a Potent Recombinant Lectin-Toxin Fusion Protein to Eliminate Human Pluripotent Stem Cells. Tateno H; Saito S Molecules; 2017 Jul; 22(7):. PubMed ID: 28698527 [TBL] [Abstract][Full Text] [Related]
7. Vinblastine treatment decreases the undifferentiated cell contamination of human iPSC-derived intestinal epithelial-like cells. Ichikawa M; Negoro R; Kawai K; Yamashita T; Takayama K; Mizuguchi H Mol Ther Methods Clin Dev; 2021 Mar; 20():463-472. PubMed ID: 33614822 [TBL] [Abstract][Full Text] [Related]
8. Comparison between the cultures of human induced pluripotent stem cells (hiPSCs) on feeder-and serum-free system (Matrigel matrix), MEF and HDF feeder cell lines. Ghasemi-Dehkordi P; Allahbakhshian-Farsani M; Abdian N; Mirzaeian A; Saffari-Chaleshtori J; Heybati F; Mardani G; Karimi-Taghanaki A; Doosti A; Jami MS; Abolhasani M; Hashemzadeh-Chaleshtori M J Cell Commun Signal; 2015 Sep; 9(3):233-46. PubMed ID: 25820945 [TBL] [Abstract][Full Text] [Related]
9. In vitro detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human induced pluripotent stem cells. Kuroda T; Yasuda S; Sato Y Methods Mol Biol; 2014; 1210():183-92. PubMed ID: 25173169 [TBL] [Abstract][Full Text] [Related]
10. Highly sensitive droplet digital PCR method for detection of residual undifferentiated cells in cardiomyocytes derived from human pluripotent stem cells. Kuroda T; Yasuda S; Matsuyama S; Tano K; Kusakawa S; Sawa Y; Kawamata S; Sato Y Regen Ther; 2015 Dec; 2():17-23. PubMed ID: 31245455 [TBL] [Abstract][Full Text] [Related]
11. Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells. Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Mizuguchi H; Sato Y Sci Rep; 2019 Mar; 9(1):3630. PubMed ID: 30842516 [TBL] [Abstract][Full Text] [Related]
12. Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. Kuroda T; Yasuda S; Kusakawa S; Hirata N; Kanda Y; Suzuki K; Takahashi M; Nishikawa S; Kawamata S; Sato Y PLoS One; 2012; 7(5):e37342. PubMed ID: 22615985 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355 [TBL] [Abstract][Full Text] [Related]
14. Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder. Mobarra N; Soleimani M; Kouhkan F; Hesari Z; Lahmy R; Mossahebi-Mohammadi M; Arefian E; Jaafarpour Z; Nasiri H; Pakzad R; Tavakoli R; Pasalar P Int J Hematol Oncol Stem Cell Res; 2014 Oct; 8(4):20-9. PubMed ID: 25774264 [TBL] [Abstract][Full Text] [Related]
15. Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. Conesa C; Doss MX; Antzelevitch C; Sachinidis A; Sancho J; Carrodeguas JA Stem Cell Rev Rep; 2012 Mar; 8(1):116-27. PubMed ID: 21617963 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs). Suchorska WM; Augustyniak E; Richter M; Trzeciak T Stem Cell Rev Rep; 2017 Apr; 13(2):299-308. PubMed ID: 27987073 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560 [TBL] [Abstract][Full Text] [Related]
18. SSEA-1-positive fibronectin is secreted by cells deviated from the undifferentiated state of human induced pluripotent stem cells. Watanabe T; Saito S; Hiemori K; Kiyoi K; Mawaribuchi S; Haramoto Y; Tateno H Biochem Biophys Res Commun; 2020 Aug; 529(3):575-581. PubMed ID: 32736676 [TBL] [Abstract][Full Text] [Related]